Master In silico drug design (ISDD) / innovation thérapeutique assistée par ordinateur à l'interface chimie biologie

Paris Diderot University

This report does not have a validity period, but it is older than 6 years and thus considered part of the historic record.
Part of the obligatory external QA system
HCERES: Programme evaluation
  • Programme
    Master In silico drug design (ISDD) / innovation thérapeutique assistée par ordinateur à l'interface chimie biologie
  • Qualification/award
  • Level
    second cycle (NQF 7)
  • Programme type
    Full recognised degree programme